What does it really mean to lead with EHRs in life underwriting? In this episode, experts from Munich Re Life US and MIB explore how an EHR first strategy can improve cycle time, reduce evidence costs, and strengthen mortality protection. The conversation examines real world use cases, evolving data quality, and why sequencing underwriting evidence differently can unlock greater value earlier in the process, along with what's next as EHR adoption continues to accelerate across the industry.

Some views and opinions expressed on this podcast may not reflect those of Munich Re Life US or its affiliates. Commentary provided in this podcast should not be construed as legal, underwriting, financial, or other type of advice.